Zobrazeno 1 - 10
of 15
pro vyhledávání: '"O. V. Mukhin"'
Autor:
A V Pivnik, G A Dudina, A A Petrenko, M V Tumanova, N I Stuklov, R A Leyghton, L I Nikerova, M G Dubnitskaya, O V Mukhin, N V Kremneva, V S Fedorova
Publikováno v:
Современная онкология, Vol 20, Iss 1, Pp 11-16 (2018)
Relevance. The distribution of patients of the oncohematological department according to the main nosological units reflecting the main hematological diseases of the elderly and senile patients, Hodgkin's lymphoma young patients of and HIV-infected p
Externí odkaz:
https://doaj.org/article/e9661ccac6fc472fbb9d03fd2cd184bd
Autor:
A V Pivnik, M V Tumanova, A V Chistyakova, G A Dudina, M G Dubnitskaya, O V Mukhin, E P Sergeeva
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 105-111 (2017)
The authors give their own data in the first Russian publication on 170 patients with lymphomas and hepatitis concurrent with HIV infection, on the distribution of therapy regimens by nosological entities and the number of deaths. Conventional protoc
Externí odkaz:
https://doaj.org/article/2559bfc4fa114c519ee3e0484c11a00b
Autor:
A V Chistyakova, N I Stuklov, M V Tumanova, M G Dubnitskaya, O V Mukhin, E P Shtyrlina, A V Pivnik
Publikováno v:
Современная онкология, Vol 18, Iss 5, Pp 36-38 (2016)
Due to the use of HAART, the efficacy of the treatment of AIDS-related lymphomas and indicators of survival in patients are close to those in the general population of lymphoma patients without HIV. According to the data of department of hematology a
Externí odkaz:
https://doaj.org/article/6e09239e7cc846c09aacd3d5c65cb61b
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 464-470 (2017)
Aim. Analysis of 37 published and 2 author's cases of multiple myeloma (MM) in HIV-positive patients. Materials & Methods. Description of 37 patients and 2 author's previously unpublished observations. Results. The median age of patients was 37 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f5366262ac4819c338f852a411c833
https://doi.org/10.21320/2500-2139-2017-10-4-464-470
https://doi.org/10.21320/2500-2139-2017-10-4-464-470
Autor:
O V Mukhin, M V Tumanova, N I Stuklov, A V Chistyakova, E P Shtyrlina, M G Dubnitskaya, A V Pivnik
Publikováno v:
Современная онкология, Vol 18, Iss 5, Pp 36-38 (2016)
Due to the use of HAART, the efficacy of the treatment of AIDS-related lymphomas and indicators of survival in patients are close to those in the general population of lymphoma patients without HIV. According to the data of department of hematology a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::098e939894e9a95d67d4069f2f54b18c
https://doi.org/10.26442/1815-1434_2016.5.36-38
https://doi.org/10.26442/1815-1434_2016.5.36-38
Publikováno v:
Bulletin of Experimental Biology and Medicine. 136:183-185
Study of polymorphism in MDR1 gene exons 21 and 26 revealed that T2677T and T3435T alleles are not a factor predisposing to lymphoproliferative diseases, but they determine the efficiency chemotherapy. Individuals with T2677T and T3435T haplotypes ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a4d569b3211526441398b79fc218459
https://doi.org/10.1023/a:1026331326648
https://doi.org/10.1023/a:1026331326648
Publikováno v:
Bulletin of experimental biology and medicine. 140(1)
Parameters of hemogram and myelogram were studied in patients with aggressive and indolent non-Hodgkin's lymphomas: the relationships between the parameters recorded before treatment and during remission or progress 6 months after chemotherapy were s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8df96dea84f4b96ed473d2724706f8
https://pubmed.ncbi.nlm.nih.gov/16254628
https://pubmed.ncbi.nlm.nih.gov/16254628
Publikováno v:
Bulletin of experimental biology and medicine. 138(4)
Study of MDR1 polymorphism in intron 6 and exon 12 of healthy individuals and patients with chronic lymphoproliferative diseases showed that the presence of mutant 6+139T allele is a factor determining resistance to lymphoproliferative diseases. Comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5980067df2f0ddfd3fe7b99f113c1ab9
https://pubmed.ncbi.nlm.nih.gov/15665957
https://pubmed.ncbi.nlm.nih.gov/15665957
Autor:
N. P. Domnikova, O. V. Mukhin, E. V. Mel’nikova, E. V. Vorontsova, A. Yu. Grishanova, V. V. Lyakhovich
Publikováno v:
Bulletin of experimental biology and medicine. 136(5)
Functional activity of P-glycoprotein in lymphocytes of patients with lymphoproliferative diseases was studied using rhodamine 123. Functional activity of P-glycoprotein in patients receiving a course of chemotherapy was lower than in controls. P-gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95862a789199f9a7e2c9e7cb88082c9
https://pubmed.ncbi.nlm.nih.gov/14968167
https://pubmed.ncbi.nlm.nih.gov/14968167
Publikováno v:
Bulletin of experimental biology and medicine. 136(2)
Study of polymorphism in MDR1 gene exons 21 and 26 revealed that T2677T and T3435T alleles are not a factor predisposing to lymphoproliferative diseases, but they determine the efficiency chemotherapy. Individuals with T2677T and T3435T haplotypes ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2093ee31fe042e64d7e7bdb6c95f8f43
https://pubmed.ncbi.nlm.nih.gov/14631505
https://pubmed.ncbi.nlm.nih.gov/14631505